The Immune Targeting in Blood Cancers Laboratory focuses on understanding the interplay between immunity and cancer cells in haematological malignancies such as multiple myeloma, B-cell lymphoma, and leukaemia.  Although immunotherapy has emerged as an important treatment option, these aggressive cancers are still difficult to cure.  Using preclinical models and clinical samples, the group aims to understand how cancer cells escape the immune system, and to develop new therapeutic approaches to prevent relapse.